Status:
UNKNOWN
CE-IOUS for Patients With Pancreatic Cancer Undergoing Surgery: A Prospective, Proof-of-concept Trial
Lead Sponsor:
University of Thessaly
Conditions:
Pancreatic Cancer
Liver Metastases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
BACKGROUND: Pancreatic Cancer (PC) is one of the leading cancer-related causes of death worldwide, with the majority of patients undergoing potentially curative surgery. In this context, the implement...
Detailed Description
1\. Introduction Pancreatic cancer is one of the most lethal types of cancer. In fact, is usually detected in an advanced stage, thus being associated with a poor prognosis. Therefore, every surgical ...
Eligibility Criteria
Inclusion
- Patients aged \> 18 years
- Patients with resectable pancreatic cancer
- Patients with borderline resectable pancreatic cancer
- Patients with locally advanced (+/- neoadjuvant-treatment) pancreatic cancer
Exclusion
- Allergy
- Uncontrolled ischemic heart disease
- Severe arrhythmias
- Pregnancy
- Breastfeeding
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04683497
Start Date
January 1 2021
End Date
December 31 2023
Last Update
January 6 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.